Pharmacogenetic Testing
personalized medication selection and dosing
Pharmacogenetic testing evaluates how genetic differences affect the way medications are metabolized and how individuals respond to treatment.
Variants in genes involved in drug metabolism can significantly influence:
Medication effectiveness
Side-effect risk
Optimal dosing
Why Pharmacogenetics Matters
This testing helps clinicians:
Select medications more precisely
Reduce adverse drug reactions
Minimize trial-and-error prescribing
Improve treatment outcomes
Pharmacogenetic insights can inform care across multiple specialties, including psychiatric, cardiovascular, endocrine, and pain management therapies.
Testing Options for Medication Genetic Testing
Medication genetic testing evaluates genetic variants that affect how your body processes and responds to medications. At CMoC, testing options range from focused pharmacogenetic panels to more comprehensive genomic analyses, depending on your medications, medical history, and treatment goals.
Some options focus on specific medication classes—such as psychiatric, cardiovascular, endocrine, or pain management therapies—while broader testing evaluates medication response across multiple systems. For patients who choose whole genome sequencing, pharmacogenetic insights may be included as part of a more comprehensive evaluation.
Your clinician will help determine which testing approach is most appropriate, ensuring results are actionable and directly inform your care.
Genesight by Myraid - billed to insurance
GeneSight is a pharmacogenomic test that analyzes multiple genes involved in drug metabolism and response, particularly for psychiatric and neurologic medications.
The report categorizes medications into “use as directed,” “moderate interaction,” and “significant interaction” tiers, improving treatment outcomes and reducing trial-and-error prescribing.
MIRA by Precision Health - up to $330
Mira is a comprehensive pharmacogenetic testing platform that assesses how genetic variations impact metabolism across a wide range of medication classes—including cardiovascular, pain management, endocrine, and psychiatric drugs.
It uses advanced bioinformatics to generate individualized reports that inform optimal drug choice, dosing, and potential interactions.
MyOme - $575 base/$775 plus
Through its whole genome sequencing approach, MyOme includes pharmacogenomic analysis to evaluate genetic variants affecting drug metabolism, transport, and receptor sensitivity.
This broad, genome-wide framework identifies both known and novel pharmacogenetic associations, allowing clinicians to personalize therapy across multiple specialties.
MyOme’s pharmacogenomic data can be reinterpreted as new gene–drug associations are discovered, supporting lifelong precision prescribing.
Wondering If Medication Genetic Testing Could Help?
If you’ve experienced side effects, limited benefit from medications, or are starting new therapies, a conversation with your care team can help clarify whether genetic testing may be useful.